Frontier Medicines
PrivateLast Round
Series C
Feb 22, 2024
Total Funding Raised
$255.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Frontier Medicines is a clinical-stage biopharmaceutical company that develops precision medicines for genetically-defined patient populations by utilizing a proprietary chemoproteomics and machine learning platform to target previously 'undruggable' proteins.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Precision Medicine, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frontier Medicines Comparables
Compare Frontier Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 85% | |
| Iambic Therapeutics | 85% | |
| Antares Therapeutics | 85% | |
Frontier Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 22, 2024 | ||||
| Series B | Jul 19, 2021 | ||||
| Series A | Jun 25, 2019 |
Key People
Founding team and executive leadership
Frontier Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series B, Series C, Series A |
| MPM Capital | Series C, Series B, Series A |
| RA Capital Management | Series C, Series A, Series B |
| DCVC Bio | Series C, Series A |
| Deep Track Capital | Series C, Series B |
| MPM BioImpact | Series C, Series B, Series A |
| Droia Ventures | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Partnered with LG Chem for FMC-220, a p53 activator.
- Mar 17, 2026
Launched the AI-powered Frontier Platform at AACR Annual Meeting 2026.
Frontier Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Frontier Medicines's valuation, stock price, and market status.